Regeneron Pharmaceuticals Inc. | Balance Sheet
Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
694
900
1,045
1,039
1,410
2,810
Total Accounts Receivable
892
1,017
1,468
1,612
1,974
2,243
Inventories
70
129
239
399
726
1,151
Other Current Assets
141
121
164
131
225
243
Total Current Assets
1,797
2,167
2,915
3,180
4,335
6,448
Net Property, Plant & Equipment
527
974
1,594
2,083
2,359
2,576
Total Investments and Advances
390
460
632
864
1,486
1,755
Other Assets
5
3
6
20
78
127
Total Assets
2,951
3,872
5,630
6,983
8,812
11,735
ST Debt & Current Portion LT Debt
1
-
-
127
-
Accounts Payable
62
100
141
135
178
Income Tax Payable
-
-
-
-
236
Other Current Liabilities
236
555
670
743
957
Total Current Liabilities
299
655
811
1,241
1,135
Long-Term Debt
505
458
363
352
703
Deferred Taxes
232
267
462
825
506
Other Liabilities
196
217
780
931
781
Total Liabilities
999
1,330
1,976
2,533
2,668
Common Equity (Total)
1,952
2,542
3,655
4,449
6,144
Total Shareholders' Equity
1,952
2,542
3,655
4,449
6,144
Total Equity
1,952
2,542
3,655
4,449
6,144
Liabilities & Shareholders' Equity
2,951
3,872
5,630
6,983
8,812
About Regeneron Pharmaceuticals
View Profile
